Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 8354747, 8 pages
https://doi.org/10.1155/2018/8354747

Research Article

The Associations between Infertility and Antioxidants, Proinflammatory Cytokines, and Chemokines

Dorota Chyra-Jach,¹ Zbigniew Kaletka,² Michał Dobrakowski,¹ Anna Machoń-Grecka,¹ Sławomir Kasperczyk,¹ Ewa Birkner,¹ and Aleksandra Kasperczyk¹

¹Department of Biochemistry, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland
²Department and Clinic of Urology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, ul. 3 Maja 13-15, 41-800 Zabrze, Poland

Correspondence should be addressed to Anna Machoń-Grecka; anna.machon-grecka@med.sum.edu.pl

Received 18 April 2018; Accepted 19 June 2018; Published 16 July 2018

Academic Editor: Karolina Szewczyk-Golec

Copyright © 2018 Dorota Chyra-Jach et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The aim of the study was to evaluate the parameters of oxidative stress and antioxidant defense in relation to the levels of proinflammatory cytokines and chemokines in patients diagnosed with oligozoospermia and asthenozoospermia. Based on the basic parameters of the spermogram, the examined group () was divided into three groups: oligospermic group (sperm count less than 15 × 10⁶/ml) consisting of 152 men, astenozoospermic group (less than 40% of progressively moving sperm cells) consisting of 142 men, and oligoastenozoospermic group (both criteria met) consisting of 90 men. The control group consisted of 103 males with normal semen profile according to the WHO criteria. Total superoxide dismutase (SOD) activity in seminal plasma and spermatozoa lysate was significantly lower by 12% and 22%, respectively, in males with oligospermia than in the control group. Analogically, Mn-SOD activity in spermatozoa lysate was significantly lower in males with oligospermia, asthenospermia, and oligoasthenospermia by 44%, 32%, and 45%, respectively. By contrast, CuZn-SOD activity in spermatozoa lysate was significantly higher in males with oligospermia by 60%. The activity of glutathione peroxidase (GPx) in seminal plasma was also significantly higher in males with oligospermia and oligoasthenospermia by 56% and 78%, respectively. The level of malondialdehyde (MDA) in seminal plasma was significantly higher in males with asthenospermia than in the control group by 12%. By contrast, the level of MDA in spermatozoa lysate was significantly lower in males with oligospermia, asthenospermia, and oligoasthenospermia by 26%, 20%, and 26%, respectively. The level of interleukin- (IL-) 8 in seminal plasma was significantly higher in males with asthenospermia and oligoasthenospermia by 64% and 67%, respectively. Abnormalities in spermogram, such as oligospermia, asthenospermia, and oligoasthenospermia, may be related to a decreased activity of Mn-SOD in spermatozoa and increased levels of chemokines in seminal plasma.

1. Introduction

The failure to conceive after one year of regular, unprotected intercourse with the same partner is defined as infertility [1]. The male factor is the cause of infertility in couples in approximately 30–40% of cases [2]. Defective sperm function is the most common cause of male infertility. Abnormal semen parameters include decreased sperm concentration, impaired motility, and altered morphology. There are many possible endogenous and exogenous factors that influence sperm quality. Many studies indicate that oxidative stress should be regarded as a plausible cause of idiopathic male infertility [3].

In spermatozoa, the NADPH oxidase at the level of the sperm plasma membrane and the NADH-dependent oxidoreductase at the mitochondrial level are the two major sources of reactive oxygen species (ROS). In seminal plasma, the main exogenous sources of ROS are radiation and toxins, including tobacco smoke and alcohol, while the main endogenous sources of ROS include the pathophysiologic effects of varicocele, accumulation of damaged spermatozoa with excess residual cytoplasm, and immune cells. Various intracellular or extracellular stimuli, such as infection or inflammation, may recruit and activate peroxidase-positive leukocytes, including polymorphonuclear leukocytes and macrophages that originate from the prostate and seminal vesicles. These cells are able to discharge up to 100 times more ROS than normal as a result of a respiratory burst. Consistently, many studies indicate a correlation between decreased sperm function and elevated levels of proinflammatory cytokines [4].

At low concentrations, ROS play an important role in capacitation, hyperactivation, acrosome reaction, and spermatozoa-oocyte fusion. However, elevated levels of ROS override antioxidant defenses and lead to a damage to biomolecules such as lipids, proteins, and nucleic acids [5]. Human spermatozoa are extremely vulnerable to oxidative attack because they contain high amounts of polyunsaturated fatty acids and little cytoplasm sequestering antioxidants. Therefore, human seminal plasma serves as a source of antioxidants. In this microenvironment, antioxidant enzymes, such as superoxide dismutase (SOD) and catalase (CAT), can be found. Besides, seminal plasma contains high levels of nonenzymatic antioxidants, such as ascorbate or thiol groups [6].

Oxidative stress-induced loss of membrane integrity, increased cell permeability, enzyme inactivation, structural damage of DNA, and cell death may be associated with decreased sperm count and motility [1, 4]. In light of this, we decided to evaluate the parameters of oxidative stress and antioxidant defense in relation to the levels of proinflammatory cytokines and chemokines in males diagnosed with oligospermia and asthenospermia.

2. Materials

The study group consisted of 346 males living in Upper Silesia (Poland) who had attended an andrology clinic to diagnose infertility. Information about the fertile abilities of men was provided by the spermogram test. The seminal samples were collected by masturbation after 3 days of abstinence on the same day in the morning before the first meal. All of the semen specimens were analyzed according to WHO standards [7], including the assessment of seminal volume, sperm cell density, total sperm cell count, motility, supravital eosin staining (for percentage of live spermatozoa), and number of peroxidase-positive cells. Additively, we analyzed percentages of motile spermatozoa after 24 hours and progressive motile spermatozoa after 24 hours.

Based on the basic parameters of the spermogram, the examined group was selected (). Subjects in that group were divided into three groups: oligospermic group (sperm count less than 15 × 10⁶/ml) consisting of 152 men, astenozoospermic group (less than 40% of progressively moving sperm cells) consisting of 142 men, and oligoastenozoospermic group (both criteria met) consisting of 90 men. The control group consisted of 103 males with normal semen profile according to the WHO criteria [7]. The exclusion criteria were defined as follows: drug consumption (including antioxidant medications), smoking habits, alcohol abuse, and a history of any chronic disease, such as diabetes, coronary artery disease, or malignant neoplasm.

The experimental set-up has been approved by the Bioethics Committee of the Medical University of Silesia in Katowice (KNW/0022/KB1/I/13/09).

3. Methods

3.1. Sample Preparation and Semen Analysis

The semen specimens were analyzed according to WHO standards [7].

After complete liquefaction, seminal plasma was separated from the spermatozoa by centrifugation at 6000 for 10 minutes. The supernatants obtained were stored at −75°C until required for the biochemical analysis. In addition, a 10% spermatozoa lysate in bidistilled water was made.

3.2. Biochemical Analysis

3.2.1. Antioxidant Enzymes

The method of Oyanagui [8] was used to measure the activities of SOD, CuZn-SOD, and Mn-SOD in seminal plasma and spermatozoa. The enzymatic activity of SOD was expressed in nitric units. The activity of SOD is equal to 1 nitric unit (NU) when it inhibits nitric ion production by 50%. Activities of SOD and isoenzymes, Mn-SOD and CuZn-SOD, in seminal plasma were expressed in NU/ml and in NU/dl packed spermatozoa. The seminal plasma glutathione peroxidase (GPx) activity was measured by the kinetic method of Paglia and Valentine [9]. The GPx activity was expressed in U/l. The activity of seminal plasma glutathione-S-transferase (GST) was measured according to the kinetic method of Habig and Jakoby [10]. The GST activity was expressed as moles of thioether produced per minute per liter of seminal plasma (U/l). The activities of glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase (GR) in seminal plasma were measured according to Richterich [11]. G6PD and GR activity was expressed as μmol of NADPH produced and utilized, respectively, per minute per liter of seminal plasma (U/l). CAT activity in seminal plasma was measured by the method of Johansson and Borg [12]. The activity of catalase was expressed as U/l.

3.2.2. Nonenzymatic Antioxidants

Total antioxidant capacity (TAC) was measured according to Erel [13]. Data were shown as mmol/l. The levels of uric acid (UA), bilirubin, and albumin were determined in seminal plasma by colorimetric methods. For uric acid and bilirubin, concentrations are provided in mg/dl, and albumin is expressed in g/ml. The concentration of thiol groups (SH) in seminal plasma was determined by Koster et al. [14]. The results were shown as μmol/l.

3.2.3. Markers of Oxidative Stress

The level of malondialdehyde (MDA) in seminal plasma and spermatozoa lysate according to Ohkawa et al. [15]. TBARS values are expressed as malondialdehyde (MDA) equivalents. Concentrations were given in μmol/l in seminal plasma and μmol/dl in packed spermatozoa. The lipofuscin (LPS) concentration was determined in seminal plasma according to Jain [16]. Values were presented as relative units (relative fluorescence lipid extract, RF). Total oxidant status (TOS) was measured in seminal plasma according to Erel [17]. Data were shown in μmol/l.

3.2.4. Cytokines

The levels of IL-1β, IL-6, IL-8, IL-12, TNF-α, MCP-1, and MIP-1β were measured in seminal plasma using a Bio-Plex 200 System (Bio-Rad Laboratories Inc., USA) according to the manufacturer’s instructions. Data were presented in pg/ml.

3.3. Statistical Analysis

A database was created in MS Excel 2007. Statistical analysis was performed using Statistica 10.0 PL software. Statistical methods included mean and standard deviation (SD) for normal distribution and median and interquartile range (IQR) for abnormal distribution. Shapiro-Wilk’s test was used to verify normality and Levene’s test to verify homogeneity of variances. Statistical comparisons between groups were made by a -test, -test with a separate variance, or Mann–Whitney test (nonparametric test). Spearman’s coefficient R for nonparametric correlation was calculated. A value of was considered significant.

4. Results

Mean age in the control and examined groups did not differ significantly (Table 1). Differences between the control group and examined groups in terms of the semen volume, pH, count, and motility are presented in Table 1. The numbers of peroxidase-positive cells were within the normal ranges (<1 × 10⁶/ml) in all examined groups and did not differ among them.

Table 1: Age, semen analysis in control and study groups; value—-test.

Control

Oligospermia

Asthenospermia

Oligoasthenospermia

Mean
SD
Mean
SD
Relative change
value
Mean
SD
Relative change
value
Mean
SD
Relative change
value

Age (years)
33
6
34
5
2%
0.432
34
6
3%
0.256
34
5
2%
0.403

Sperm volume (ml)
3.70
1.73
3.58
1.53
−3%
0.541
3.42
1.63
−8%
0.186
3.41
1.58
−8%
0.214

pH value
7.56
0.08
7.57
0.09
0%
0.646
7.57
0.08
0%
0.783
7.56
0.09
0%
0.915

Sperm cells count in 1 ml (mln/ml)
79.5
60.1
4.39
4.51
−94%
<0.001
25.4
42.8
−68%
<0.001
3.81
4.68
−95%
<0.001

Total sperm cells count (mln)
269
189
15.5
19.9
−94%
<0.001
73.9
122
−73%
<0.001
12.5
19.8
−95%
<0.001

Total motility after 1 hour (% motile)
58.1
9.48
32.4
20.6
−44%
<0.001
22.9
14.0
−61%
<0.001
18.3
14.1
−69%
<0.001

Rapid progressive motility (a) after 1 hour (%)
26.0
9.96
9.16
7.82
−65%
<0.001
6.75
5.97
−74%
<0.001
5.14
5.55
−80%
<0.001

Slow progressive motility (b) after 1 hour (%)
18.0
6.81
9.53
8.11
−47%
<0.001
6.76
7.13
−62%
<0.001
4.77
4.98
−73%
<0.001

Progressive motility (a + b) after 1 hour (%)
44.0
9.74
18.7
14.22
−57%
<0.001
13.5
10.66
−69%
<0.001
9.9
9.41
−77%
<0.001

.

Total SOD activity in seminal plasma and spermatozoa lysate was significantly lower by 12% and 22%, respectively, in males with oligospermia than in the control group. Analogically, Mn-SOD activity in spermatozoa lysate was significantly lower in males with oligospermia, asthenospermia, and oligoasthenospermia by 44%, 32%, and 45%, respectively. By contrast, CuZn-SOD activity in spermatozoa lysate was significantly higher in males with oligospermia by 60%. The activity of GPx in seminal plasma was also significantly higher in males with oligospermia and oligoasthenospermia by 56% and 78%, respectively (Table 2).

Table 2: Antioxidant enzyme activity in seminal plasma and spermatozoa (SOD: superoxide dismutase; CAT: catalase; GR: glutathione reductase; GPx: glutathione peroxidase; GST: glutathione-S-transferase; G6PD: glucose-6-phosphate dehydrogenase; value—-test.

Control
Oligospermia
Asthenospermia
Oligoasthenospermia

Mean
SD
Mean
SD
Relative change
value
Mean
SD
Relative change
value
Mean
SD
Relative change
value

Total SOD activity (NU/ml)
183
55.5
162
55.6
−12%
0.004
169
53.3
−8%
0.062
170
50.8
−7%
0.087

Mn-SOD activity (NU/ml)
37.6
44.0
31.7
36.1
−16%
0.317
37.1
43.6
−1%
0.935
32.9
34.2
−12%
0.504

CuZn SOD activity (NU/ml)
143
49.8
129
52.2
−10%
0.063
133
52.0
−7%
0.210
138
43.6
−3%
0.555

CAT activity (U/l)
607
460
573
336
−6%
0.547
608
413
0%
0.986
579
352
−5%
0.685

GR activity (U/l)
78.8
85.7
70.0
71.2
−11%
0.378
69.0
73.3
−12%
0.341
70.3
74.9
−11%
0.474

GPx activity (U/l))
118
210
184
276
56%
0.039
187
301
58%
0.051
210
284
78%
0.007

GST activity (U/l)
3.75
2.96
3.34
2.05
−11%
0.837
3.29
2.18
−12%
0.187
3.64
2.30
−3%
0.787

G6PD activity (U/l)
64.8
53.0
63.7
45.9
−2%
0.701
55.2
44.9
−15%
0.251
58.8
46.0
−9%
0.531

Total SOD activity (NU/dl packed spermatozoa)
152
75.4
119
75.3
−22%
0.045
128
78.8
−16%
0.198
118
75.8
−22%
0.106

Mn-SOD activity (NU/dl packed spermatozoa)
135
66.7
75.3
51.5
−44%
<0.001
90.9
57.7
−32%
0.007
73.9
51.8
−45%
0.001

CuZn SOD activity (NU/dl packed spermatozoa)
33.7
19.4
53.9
42.0
60%
0.019
46.2
35.9
37%
0.095
48.6
41.6
44%
0.093

.

The level of UA in seminal plasma was significantly higher in males with oligoasthenospermia than in the control group by 19%, while the level of albumin in seminal plasma was significantly lower in males with oligospermia by 12% (Table 3).

Table 3: Antioxidant reserves in seminal plasma and spermatozoa (thiol group concentration (SH concentration), total antioxidant capacity (TAC); value—-test.

Control
Oligospermia
Asthenospermia
Oligoasthenospermia

Mean
SD
Mean
SD
Relative change
value
Mean
SD
Relative change
value
Mean
SD
Relative change
value

SH concentration (μmol/l)
211
86.6
198
84.6
−6%
0.304
196
91.6
−7%
0.279
199
87.7
−6%
0.432

TAC (mmol/l)
1.33
0.24
1.31
0.30
−1%
0.785
1.34
0.28
1%
0.814
1.35
0.33
2%
0.690

Uric acid concentration (mg/dl)
4.39
1.40
4.96
2.35
13%
0.079
4.90
2.54
12%
0.142
5.20
2.89
19%
0.045

Bilirubin (mg/dl)
0.12
0.17
0.10
0.13
−15%
0.445
0.14
0.23
17%
0.567
0.12
0.16
3%
0.906

Albumin (g/ml)
0.49
0.16
0.43
0.15
−12%
0.007
0.45
0.16
−8%
0.052
0.44
0.17
−10%
0.118

.

The level of MDA in seminal plasma was significantly higher in males with asthenospermia than in the control group by 12%. By contrast, the level of MDA in spermatozoa lysate was significantly lower in males with oligospermia, asthenospermia, and oligoasthenospermia by 26%, 20%, and 26%, respectively (Table 4).

Table 4: Parameters related to oxidative stress intensity in seminal plasma and spermatozoa (MDA: malondialdehyde; TOS: total oxidant status); value—-test.

Control
Oligospermia
Asthenospermia
Oligoasthenospermia

Mean
SD
Mean
SD
Relative change
value
Mean
SD
Relative change
value
Mean
SD
Relative change
value

MDA concentration (μmol/dl packed spermatozoa)
0.56
0.19
0.41
0.09
−26%
<0.001
0.45
0.12
−20%
0.006
0.42
0.09
−26%
0.002

MDA concentration (μmol//l)
2.41
0.98
2.63
1.18
9%
0.125
2.71
1.13
12%
0.031
2.69
1.20
11%
0.087

Lipofuscin (RF)
3.92
1.57
3.84
1.35
−2%
0.705
3.86
1.26
−1%
0.786
3.91
1.33
0%
0.971

TOS (μmol/l)
11.0
13.8
8.23
13.2
−25%
0.248
9.72
13.5
−12%
0.591
8.62
14.8
−22%
0.409

.

The level of IL-12 in seminal plasma was significantly lower in males with oligoasthenospermia than in the control group by 50%. At the same time, the level of IL-8 in seminal plasma was significantly higher in males with asthenospermia and oligoasthenospermia by 64% and 67%, respectively. Analogically, the level of MCP-1 in seminal plasma was significantly higher by 47% and 64%, respectively. The level of MIP-1β in seminal plasma was significantly higher in males with oligospermia, asthenospermia, and oligoasthenospermia than in the control group by 57%, 47%, and 49%, respectively (Table 5).

Table 5: Concentrations of cytokines in seminal plasma (IL-1β: interleukin 1β; IL-6: interleukin 6; IL-8: interleukin 8; IL-12 interleukin 12; MCP-1: monocyte chemoattractant protein-1; MIP-1β: macrophage inflammatory protein 1-β; TNF-α: tumor necrosis factor α; -value—Mann–Whitney test.

Control
Oligospermia
Asthenospermia
Oligoasthenospermia

Median
IQR
Median
IQR
relative change
value
Median
IQR
relative change
value
Median
IQR
relative change
value

IL-1β (pg/ml)
1.21
2.61
1.98
10.52
64%
0.164
1.66
9.90
37%
0.134
1.65
9.93
36%
0.198

IL-6 (pg/ml)
9.97
13.0
13.5
18.7
35%
0.161
15.90
16.4
59%
0.177
17.0
17.4
71%
0.064

IL-8 (pg/ml)
155
157
242
371
56%
0.092
254
437
64%
0.017
259
423
67%
0.038

IL-12 (pg/ml)
2.80
3.72
1.56
3.40
−44%
0.108
2.22
3.74
−21%
0.296
1.39
2.99
−50%
0.041

MCP-1 (pg/ml)
992
1181
1347
1411
36%
0.221
1457
1387
47%
0.038
1624
1467
64%
0.041

MIP-1β (pg/ml)
50.9
31.0
79.8
111
57%
0.006
74.9
76.7
47%
0.013
75.8
72.2
49%
0.016

TNF-α (pg/ml)
4.13
3.39
3.73
4.16
−10%
0.326
3.88
3.68
−6%
0.361
3.67
4.16
−11%
0.318

IQR: interquartile range, .

Spearman correlations showed positive correlations between the sperm cell count and motility and spermatozoa Mn-SOD activity (, ) and spermatozoa MDA (, ) as well as albumin concentration in seminal plasma (, ). By contrast, the level of MDA, MCP-1, and IL-8 in seminal plasma negatively correlated with motility (R between −0.11 and −0.21, ) (Table 6).

Table 6: Spearman correlations between semen parameters and oxidative stress and cytokines.

Seminal plasma
Spermatozoa

Total SOD
Mn-SOD
GPx
MDA
Albumin
IL-8
IL-12 (p70)
MCP-1
Total SOD
Mn-SOD
CuZn-SOD
MDA

Sperm cell count in 1 ml
0.17
0.15

0.22

0.19

0.31
0.51

0.44

Total sperm cell count
0.12
0.15

0.21

0.18

0.33
0.51

0.44

Total motility after 1 hour

−0.14

−0.18

−0.21

0.26

0.23

Rapid progressive motility (a) after 1 hour

−0.24
0.25
0.47

0.36

Slow progressive motility (b) after 1 hour

−0.21
0.20

0.20
−0.18

−0.27

Progressive motility (a + b) after 1 hour

−0.11
0.15

−0.22

0.31
−0.24
0.34

Motile spermatozoa after 24 hours

−0.18

0.29

0.30
0.44

0.26

Progressive motility after 24 hours

−0.16
−0.11
0.25

0.39

0.31

R, .

5. Discussion

The activity of the antioxidant defense system in spermatozoa is limited by the low amount of their cytoplasm [18]. Nevertheless, human seminal plasma is considered as an important source of antioxidants. SOD is believed to be the first enzymatic line of antioxidant defense [1]. SOD prevents lipid peroxidation of plasma membrane through superoxide anion utilization by converting it into hydrogen peroxide. In order to prevent the toxic action of hydrogen peroxide, SOD should be conjugated with CAT or GPx [18]. Utilization of hydrogen peroxide by GPx depletes GSH pool, a cofactor which is converted to oxidized glutathione (GSSG). The recycling of GSSG into its reduced form depends on the activity of GR which needs NADPH as a reducing cofactor. The main source of NADPH is the pentose phosphate cycle in which G6PD transforms glucose-6-phosphate into phospho-6-gluconolactone releasing NADPH [19].

It has been established that SOD plays a major role in maintaining sperm viability and its activity in spermatozoa is positively correlated with duration of sperm motility [2]. Consistently, we showed positive correlations between SOD activity in spermatozoa lysate and sperm volume, sperm cell count, rapid progressive motility after 1 hour, and motile spermatozoa after 24 hours. At the same time, the percentages of nonlinear progressive and unprogressive motile spermatozoa after 1 hour correlated negatively with SOD activity in spermatozoa lysate. We reported also lower activities of SOD in seminal plasma and spermatozoa lysate of males with oligospermia than in the controls. These results confirm the proposed protective role of SOD against oxidative stress in semen. In this context, the activity of manganese isoenzyme of SOD seems to be crucial for sperm quality maintenance because we reported lower activities of Mn-SOD in spermatozoa lysate of males with oligospermia, asthenospermia, and oligoasthenospermia than in the control group. Additively, the activity of Mn-SOD positively correlated with sperm volume, sperm cell count, and sperm motility in the examined population. Consistently, in our previous study, we showed a negative association between SOD activities, including Mn-SOD, in spermatozoa and oxidative stress measured as a TOS level [20]. Mn-SOD is localized in the mitochondrial matrix. Mitochondria are responsible for energy production via the oxidative phosphorylation pathway and are one of the major sources of chronic ROS production under physiological conditions and compromised by severe and prolonged oxidative stress. Decreased Mn-SOD activity promotes generation of oxidants which inactivate enzymes and damage mtDNA leading to the disruption of mitochondrial integrity [21]. Ultimately, mitochondrial dysfunction may lead to ATP pool depletion and sperm motility impairment. Mitochondrial dysfunction associated with decreased oxidative metabolism may be an explanation for observed simultaneously paradoxically lower MDA level in spermatozoa lysate of males with oligospermia, asthenospermia, and oligoasthenospermia than in the control group. The second explanation for lower MDA level in spermatozoa is its possible leakage form damaged sperm cells due to oxidative stress and peroxidation of cell membrane lipids. Additively, in males with oligospermia, lower MDA level may be also due to a higher activity of CuZn-SOD in spermatozoa lysate. This SOD isoenzyme is localized in the cytosol with a smaller fraction in the intermembrane space of mitochondria [21]. Elevation of its activity might be a result of a compensatory defense mechanism. Higher activities of GPx in seminal plasma of males with oligospermia and oligoasthenospermia than in the control group should be interpreted in the same way. At the same time, in males with asthenospermia, antioxidant defense in seminal plasma seems to be insufficient because an elevated level of MDA in that group was observed. The levels and activities of remaining parameters of oxidative stress and antioxidant enzymes did not differ between the control and examined groups.

Results of other studies on this topic are only partially in concordance with our observations. Marzec-Wróblewska et al. [2] reported lower SOD activity in males with pathological spermogram than in the normozoospermic males. SOD activity was also negatively associated with semen volume and positively associated with rapid progressive motility, nonprogressive motility, and sperm concentration. Similarly, in a study of Zelen et al. [5], the activities of SOD and CAT were significantly lower in the seminal plasma of the oligozoospermic, astenozoospermic, and teratozoospermic patients compared to the fertile controls, while the level of MDA was higher in the infertile subjects. Analogical results were shown in a study of Shiva et al. [18] who reported a significant increase in the MDA levels in asthenozoospermics and teratozoospermics as compared to progressively motile and morphologically normal groups, respectively. A positive correlation between SOD activity and sperm count and total progressive motility was also found. Authors concluded that decline in SOD activity might be involved in the abnormal semen quality. On the other hand, Abdallah et al. [6] reported elevated activity of SOD in azoospermic, oligoasthenozoospermic, and asthenozoospermic males compared to normozoospermic ones postulating that SOD expression is upregulated in response to defective spermatogenesis or hormonal deficiency. In other analogous studies, unchanged, elevated, and decreased activities of SOD, CAT, and GPx were found in semen of infertile males compared to the fertile controls [6]. The discrepancies between studies may be due to the different study protocols and a result of action of many factors influencing antioxidant enzyme expression and activities. In light of this, as proposed Tavilani et al. [22], lack of protection against lipid peroxidation in semen of infertile males may be not due to the alteration in the activity of a particular antioxidant enzyme but rather due to a noncoordination between several of them. Consistently, Micheli et al. [23] suggested that the alteration of a single parameter of oxidative stress/antioxidant system does not have enough clinical value to estimate the male fertilizing potential.

The associations between fertility impairment and seminal nonenzymatic antioxidant defense seem to be as complex as those between antioxidant enzyme activities and spermogram parameters. Seminal plasma and spermatozoa contain nonenzymatic ROS scavengers, such vitamins, glutathione, uric acid, and albumin [24]. The antioxidant properties of albumin are attributed to the thiol groups of its cysteine residues. Albumin is believed also to sequester prooxidant molecules and redox-active metals [25]. Consistently, bovine serum albumin has been shown to protect membrane integrity of sperm cells from heat shock during freezing thawing of canine semen [26]. In light of this, significantly lower seminal plasma albumin level in males with oligospermia than in the controls should be interpret as attenuation of antioxidant defense. The antioxidant properties of uric acid are less unequivocal. On the one hand, uric acid acts as a scavenger of ROS being regarded as a main antioxidant in human plasma. On the other hand, uric acid may be a prooxidant under conditions of oxidative stress [27]. Lahnsteiner et al. [28] reported that uric acid is the primary antioxidant in semen of brown trout. Therefore, higher levels of uric acid in males diagnosed with oligoasthenospermia than in the controls may be interpret as an effect of compensatory defense mechanism; however, elevation of this metabolite level may be also due to increased purine degradation.

The inflammatory process within the male genitourinary tract was found to reduce fertilizing potential of mature spermatozoa. Recruitment of immune cells to the site of inflammation results in the release of reactive oxygen intermediates and proinflammatory cytokines by activated neutrophils and macrophages [29]. Consistently, we reported higher levels of IL-8, MCP-1, and MIP-1β in males with asthenospermia, oligoasthenospermia, and oligospermia than in the control group. All of these compounds play a role in chemokines [30]. On the other hand, the levels of proinflammatory cytokines were not simultaneously higher in males with abnormal spermogram. Camejo et al. [31] reported higher IL-6 concentration in seminal plasma of infertile men compared to fertile men, while the level of TNF-α did not differ between studied groups. At the same time, there was a positive correlation between the levels of IL-6 in seminal plasma and the levels of lipid peroxidation of the sperm membranes. However, TNF-α and IL-6 concentrations did not correlate with sperm parameters, such as normal morphology, sperm concentration, and motility, in that study. Consistently, Frączek et al. [29] concluded that proinflammatory cytokines per se are unable to cause oxidative stress in semen to the level of membrane oxidative damage. The discrepancies between studies are probably due to the complex dependences between cytokines which act inhibitory or synergistic in an array [32].

6. Conclusions

Abnormalities in spermogram, such as oligospermia, asthenospermia, and oligoasthenospermia, may be related to decreased activity of Mn-SOD in spermatozoa and increased levels of chemokines in seminal plasma.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors have no conflicts of interest to declare.

Acknowledgments

This work was supported by the Medical University of Silesia (KNW-1-103/N/7/O). The data used to support the findings of this study are available from the corresponding author upon request.

References

F. Atig, M. Raffa, H. B. Ali, K. Abdelhamid, A. Saad, and M. Ajina, “Altered antioxidant status and increased lipid per-oxidation in seminal plasma of tunisian infertile men,” International Journal of Biological Sciences, vol. 8, no. 1, pp. 139–149, 2012.

U. Marzec-Wróblewska, P. Kamiński, P. Łakota et al., “Zinc and iron concentration and SOD activity in human semen and seminal plasma,” Biological Trace Element Research, vol. 143, no. 1, pp. 167–177, 2011.

S. A. Sheweita, A. M. Tilmisany, and H. Al-Sawaf, “Mechanisms of male infertility: role of antioxidants,” Current Drug Metabolism, vol. 6, no. 5, pp. 495–501, 2005.

A. Agarwal, G. Virk, C. Ong, and S. S. du Plessis, “Effect of oxidative stress on male reproduction,” World Journal Mens Health, vol. 32, no. 1, pp. 1–17, 2014.

I. Zelen, M. Mitrović, A. Jurisic-Skevin, and S. Arsenijević, “Activity of superoxide dismutase and catalase and content of malondialdehyde in seminal plasma of infertile patients,” Medicinski Pregled, vol. 63, no. 9-10, pp. 624–629, 2010.

F. Ben Abdallah, I. Dammak, H. Attia, B. Hentati, and L. Ammar-Keskes, “Lipid peroxidation and antioxidant enzyme activities in infertile men: correlation with semen parameter,” Journal of Clinical Laboratory Analysis, vol. 23, no. 2, pp. 99–104, 2009.

WHO, The Laboratory Manual for the Examination of Human Semen, Cambridge University Press, 5 edition, 2010.

Y. Oyanagui, “Reevaluation of assay methods and establishment of kit for superoxide dismutase activity,” Analytical Biochemistry, vol. 142, no. 2, pp. 290–296, 1984.

D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967.

W. H. Habig and W. B. Jakoby, “Assays for differentiation of glutathione S-Transferases,” Methods in Enzymology, vol. 77, pp. 398–405, 1981.

R. Richterich, Chemia kliniczna, PZWL, Warszawa, 1971.

L. H. Johansson and L. A. Håkan Borg, “A spectrophotometric method for determination of catalase activity in small tissue samples,” Analytical Biochemistry, vol. 74, no. 1, pp. 331–336, 1988.

O. Erel, “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation,” Clinical Biochemistry, vol. 37, no. 4, pp. 277–285, 2004.

J. F. Koster, P. Biemond, and A. J. Swaak, “Intracellular and extracellular sulphydryl levels in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 45, no. 1, pp. 44–46, 1986.

H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.

S. K. Jain, “In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats,” The Journal of Clinical Investigation, vol. 76, no. 1, pp. 281–286, 1985.

O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005.

M. Shiva, A. K. Gautam, Y. Verma, V. Shivgotra, H. Doshi, and S. Kumar, “Association between sperm quality, oxidative stress, and seminal antioxidant activity,” Clinical Biochemistry, vol. 44, no. 4, pp. 319–324, 2011.

J. F. Griveau, E. Dumont, P. Renard, J. P. Callegari, and D. Le Lannou, “Reactive oxygen species, lipid peroxidation and enzymatic defence systems in human spermatozoa,” Journal of Reproduction and Fertility, vol. 103, no. 1, pp. 17–26, 1995.

M. Dobrakowski, S. Kasperczyk, S. Horak, D. Chyra-Jach, E. Birkner, and A. Kasperczyk, “Oxidative stress and motility impairment in the semen of fertile males,” Andrologia, vol. 49, no. 10, 2017.

T. Fukai and M. Ushio-Fukai, “Superoxide dismutases: role in redox signaling, vascular function, and diseases,” Antioxidants & Redox Signaling, vol. 15, no. 6, pp. 1583–1606, 2011.

H. Tavilani, M. T. Goodarzi, A. Vaisi-raygani, S. Salimi, and T. Hassanzadeh, “Activity of antioxidant enzymes in seminal plasma and their relationship with lipid peroxidation of spermatozoa,” International Braz J Urol, vol. 34, no. 4, pp. 485–491, 2008.

L. Micheli, D. Cerretani, G. Collodel et al., “Evaluation of enzymatic and non-enzymatic antioxidants in seminal plasma of men with genitourinary infections, varicocele and idiopathic infertility,” Andrology, vol. 4, no. 3, pp. 456–464, 2016.

E. de Lamirande, H. Jiang, A. Zini, H. Kodama, and C. Gagnon, “Reactive oxygen species and sperm physiology,” Reviews of Reproduction, vol. 2, no. 1, pp. 48–54, 1997.

M. Dobrakowski, J. Zalejska-Fiolka, T. Wielkoszyński, E. Świętochowska, and S. Kasperczyk, “The effect of occupational exposure to lead on the non-enzymatic antioxidant system,” Medycyna Pracy, vol. 65, no. 4, pp. 443–451, 2014.

O. Uysal and M. N. Bucak, “Effects of oxidized glutathione, bovine serum albumin, cysteine and lycopene on the quality of frozen-thawed ram semen,” Acta Veterinaria Brno, vol. 76, no. 3, pp. 383–390, 2007.

C. Gersch, S. P. Palii, K. M. Kim, A. Angerhofer, R. J. Johnson, and G. N. Henderson, “Inactivation of nitric oxide by uric acid,” Nucleosides, Nucleotides & Nucleic Acids, vol. 27, no. 8, pp. 967–978, 2008.

F. Lahnsteiner, N. Mansour, and K. Plaetzer, “Antioxidant systems of brown trout (Salmo trutta f. fario) semen,” Animal Reproduction Science, vol. 119, no. 3-4, pp. 314–321, 2010.

M. Frączek, D. Sanocka, M. Kamieniczna, and M. Kurpisz, “Proinflammatory cytokines as an intermediate factor enhancing lipid sperm membrane peroxidation in in vitro conditions,” Journal of Andrology, vol. 29, no. 1, pp. 85–92, 2008.

J. A. Politch, L. Tucker, F. P. Bowman, and D. J. Anderson, “Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men,” Human Reproduction, vol. 22, no. 11, pp. 2928–2935, 2007.

M. I. Camejo, L. Abdala, G. Vivas-Acevedo, R. Lozano-Hernández, M. Angeli-Greaves, and E. D. Greaves, “Selenium, copper and zinc in seminal plasma of men with varicocele, relationship with seminal parameters,” Biological Trace Element Research, vol. 143, no. 3, pp. 1247–1254, 2011.

P. Martínez, F. Proverbio, and M. I. Camejo, “Sperm lipid peroxidation and pro-inflammatory cytokines,” Asian Journal of Andrology, vol. 9, no. 1, pp. 102–107, 2007.